Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Queensland Health
Harvard Business School
Healthtrust
Moodys
UBS
Cerilliant
Argus Health
Deloitte

Generated: May 27, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 062757

« Back to Dashboard

NDA 062757 describes MEFOXIN, which is a drug marketed by Mylan Institutional and Merck and is included in four NDAs. Additional details are available on the MEFOXIN profile page.

The generic ingredient in MEFOXIN is cefoxitin sodium. There are eight drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the cefoxitin sodium profile page.
Summary for 062757
Tradename:MEFOXIN
Applicant:Mylan Institutional
Ingredient:cefoxitin sodium
Patents:0
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 062757

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrengthEQ 1GM BASE/VIAL
Approval Date:Jan 8, 1987TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrengthEQ 2GM BASE/VIAL
Approval Date:Jan 8, 1987TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
US Department of Justice
Johnson and Johnson
Cipla
Julphar
Cantor Fitzgerald
Daiichi Sankyo
Cerilliant
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.